Testing better treatment information for calciphylaxis ulcers
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 3 study is for adults on regular dialysis who have a new calciphylaxis ulcer. It tests a better way to give and use treatment guidance so ulcers may improve with clearer, more consistent care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be on hemodialysis now, or be on peritoneal dialysis and able to switch to hemodialysis
- Plan to continue dialysis at least 3 times per week for the trial treatment period
- Have a new calciphylaxis ulcer that started less than 10 weeks ago
- Both you and your doctor must agree to do all required study steps and follow the treatment plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called EPN-701 for calciphylaxis, a serious condition where calcium deposits damage blood vessels and skin, causing painful sores. If you have this condition and are on regular dialysis, this trial may help reduce your pain and heal your wounds.
This study looks at a rare condition called calciphylaxis (hardening of small blood vessels) that can happen in people with chronic kidney disease. It aims to learn more about what causes it and how to help those affected.
This study collects and stores information from people with calciphylaxis, a serious condition that causes painful skin lesions. It may help researchers learn more about the disease and improve future care.
This trial tests a drug called tocilizumab (an IL-6 blocker) for people with calciphylaxis, a painful skin condition linked to kidney disease. The goal is to see if the drug can reduce inflammation and improve skin sores.
This early-phase study tests a stem cell therapy made from amniotic (placenta) tissue for people with calciphylaxis. If you qualify, the goal is to see whether this treatment is safe and potentially helpful for this rare, painful condition.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
Hear when a new Calciphylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.